Niagen Bioscience (NAGE) Capital Expenditures (QoQ) (2011 - 2020)
Niagen Bioscience (NAGE) Capital Expenditures (QoQ) (2011 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 513.33% |
| Mar 31, 2020 | -94.64% |
| Dec 31, 2019 | 80.65% |
| Sep 30, 2019 | 124.64% |
| Jun 30, 2019 | -71.13% |
| Mar 31, 2019 | 2,290.00% |
| Dec 31, 2018 | -72.97% |
| Sep 30, 2018 | -96.68% |
| Jun 30, 2018 | 591.30% |
| Mar 31, 2018 | -45.42% |
| Dec 30, 2017 | -48.87% |
| Sep 30, 2017 | 333.83% |
| Jul 1, 2017 | -17.90% |
| Apr 1, 2017 | -71.27% |
| Dec 31, 2016 | -20.55% |
| Oct 1, 2016 | 230.79% |
| Jul 2, 2016 | 1,190.35% |
| Apr 2, 2016 | -96.48% |
| Mar 30, 2013 | -31.16% |
| Dec 29, 2012 | 596.19% |